Jacob B. Frieberg - 30 Jun 2023 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
Director
Signature
/s/ Scott E. Royer, Attorney-in-Fact for Jacob B. Frieberg
Issuer symbol
VCNX
Transactions as of
30 Jun 2023
Net transactions value
+$17,433
Form type
4
Filing time
05 Oct 2023, 16:30:13 UTC
Previous filing
15 May 2023
Next filing
25 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VCNX Common Stock 4,235 30 Jun 2023 Direct
holding VCNX Common Stock 6,301 30 Jun 2023 By Benbow Estates, Ltd. F1
holding VCNX Common Stock 12,870 30 Jun 2023 By Gee Eff Services Limited F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Award $8,739 +2,414 $3.62 2,414 30 Jun 2023 Common Stock 2,414 $5.34 Direct F9
transaction VCNX Stock Option (Right to Buy) Award $8,694 +11,291 $0.7700 11,291 29 Sep 2023 Common Stock 11,291 $1.13 Direct F10
holding VCNX Stock Option (Right to Buy) 6,396 30 Jun 2023 Common Stock 6,396 $204.00 Direct F3
holding VCNX Stock Option (Right to Buy) 2,501 30 Jun 2023 Common Stock 2,501 $78.90 Direct F3
holding VCNX Stock Option (Right to Buy) 7,718 30 Jun 2023 Common Stock 7,718 $116.70 Direct F3, F4
holding VCNX Stock Option (Right to Buy) 2,385 30 Jun 2023 Common Stock 2,385 $82.80 Direct F3
holding VCNX Stock Option (Right to Buy) 1,856 30 Jun 2023 Common Stock 1,856 $107.55 Direct F3
holding VCNX Stock Option (Right to Buy) 2,737 30 Jun 2023 Common Stock 2,737 $72.75 Direct F3
holding VCNX Stock Option (Right to Buy) 3,336 30 Jun 2023 Common Stock 3,336 $60.00 Direct F3
holding VCNX Stock Option (Right to Buy) 15,679 30 Jun 2023 Common Stock 15,679 $59.25 Direct F3, F5
holding VCNX Stock Option (Right to Buy) 3,756 30 Jun 2023 Common Stock 3,756 $54.15 Direct F3
holding VCNX Stock Option (Right to Buy) 7,626 30 Jun 2023 Common Stock 7,626 $26.70 Direct F3
holding VCNX Stock Option (Right to Buy) 6,545 30 Jun 2023 Common Stock 6,545 $31.05 Direct F3
holding VCNX Stock Option (Right to Buy) 4,535 30 Jun 2023 Common Stock 4,535 $44.70 Direct F3
holding VCNX Stock Option (Right to Buy) 28,586 30 Jun 2023 Common Stock 28,586 $32.25 Direct F3, F6
holding VCNX Stock Option (Right to Buy) 4,804 30 Jun 2023 Common Stock 4,804 $42.00 Direct F3
holding VCNX Stock Option (Right to Buy) 6,233 30 Jun 2023 Common Stock 6,233 $32.40 Direct F3
holding VCNX Stock Option (Right to Buy) 12,856 30 Jun 2023 Common Stock 12,856 $15.60 Direct F3
holding VCNX Stock Option (Right to Buy) 10,032 30 Jun 2023 Common Stock 10,032 $19.80 Direct F3
holding VCNX Stock Option (Right to Buy) 53,254 30 Jun 2023 Common Stock 53,254 $16.80 Direct F3, F7
holding VCNX Stock Option (Right to Buy) 12,064 30 Jun 2023 Common Stock 12,064 $16.20 Direct F3
holding VCNX Stock Option (Right to Buy) 26,260 30 Jun 2023 Common Stock 26,260 $7.43 Direct F3
holding VCNX Stock Option (Right to Buy) 19,852 30 Jun 2023 Common Stock 19,852 $9.68 Direct F3
holding VCNX Stock Option (Right to Buy) 32,107 30 Jun 2023 Common Stock 32,107 $5.99 Direct F3
holding VCNX Stock Option (Right to Buy) 143,848 30 Jun 2023 Common Stock 143,848 $6.15 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F2 Mr. Frieberg is the sole owner and President of Gee Eff Services Limited.
F3 Exercisable in full as of the date of this report.
F4 This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
F5 This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
F6 This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
F7 This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
F8 This option expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.
F9 Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the second quarter of 2023. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable.
F10 Pursuant to the Issuer's Director Compensation Plan, in a transaction exempt under Rule 16b-3, the reporting person elected to receive these options in lieu of $8,750 for retainer and meeting fees during the third quarter of 2023. The number of options was calculated in accordance with the Black-Scholes valuation model and all such options are immediately exercisable.

Remarks:

On September 25, 2023, Vaccinex, Inc. effected a 1-for-15 reverse stock split (the "Reverse Stock Split"). All figures in this Form 4 reflect the Reverse Stock Split.